Health Catalyst, Inc. (Health Catalyst), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Lumeon Limited (Lumeon), a digital health company…
Continue Reading
Healthcare providers across the country are launching enterprise-wide deployments of tools that use generative AI to assist with clinical documentation. Physicians are lauding these tools, saying they do a good job of reducing burnout,…
Continue Reading
What You Should Know:
– PathAI, a pioneer in AI-powered digital pathology, has achieved a significant milestone with the CE mark certification of its AISight Dx Image Management System (IMS) for primary diagnosis.
– The certification…
Continue Reading
Avi Mukherjee, Chief Product and Technology Officer of Verato
Andy Dé, Chief Marketing Officer of Verato.
Famous artificial intelligence (AI) errors such as a Google search recommendation to put glue on a pizza to keep the…
Continue Reading
What You Should Know:
– ZBiotics, the pioneers carving a new category of genetically engineered probiotics, today announced the close of its $12M Series A funding round, led by Spring Tide Capital. The oversubscribed round also includes…
Continue Reading
The following is a guest article by Bernard Steinbacher, CPC, MS, MD, and Senior Medical Director at Lyric
The landscape of laboratory payments in healthcare is complex and evolving, presenting both significant challenges and opportunities…
Top News
Publicly traded healthcare software vendor Evolent Health is reportedly considering acquisition offers from several private equity firms and insurer Elevance Health.
EVH shares are up 32% in the past year, having risen sharply…
The 340B program is a significant driver of savings and improved profit margins for health systems—for many organizations, the inclusion of a 340B program can even be the factor that makes them financially viable….
Continue Reading
What You Should Know:
– Falfurrias Management Partners (Falfurrias), a Charlotte-based private equity firm focused on growth-oriented, middle-market businesses, today announced its investment in Jumo Health, an innovative and award-winning clinical trial solutions company driving better…
Continue Reading
In the rapidly evolving world of pharmaceuticals, artificial intelligence (AI) is emerging as a game-changer. From accelerating drug discovery to enhancing the efficiency of clinical trials, AI is revolutionizing how new medicines are brought…
Continue Reading
